CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression

Virchows Archiv

Volumn 450, Issue 1, 2007, Pages 59-64

  Winkler, Alexandra ^a   Zigeuner, Richard ^a   Rehak, Peter ^a   Hutterer, Georg ^a   Chromecki, Thomas ^a   Langner, Cord ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

CD24; Prognosis; Transitional cell carcinoma; Upper urinary tract; Urothelial carcinoma

Indexed keywords

CD24 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; URINARY TRACT; UROGENITAL TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD24; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; UROLOGIC NEOPLASMS;

EID: 33847616550     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-006-0316-0     Document Type: Article

References (26)

1. Baumann P, Cremers N, Kroese F, Orend G, Chiquet-Ehrismann R, Uede T, Yagita H, Sleeman JP (2005) CD24 causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res 65:10783-10793
2. Garnier JL, Stevenson G, Blanc-Brunat N, Touraine JL, Milpied N, Leblond V, Blay JY (2002) Treatment of post-transplant lymphomas with anti-B-cell monoclonal antibodies. Recent Results Cancer Res 159:113-122
3. Genega EM, Porter CR (2002) Urothelial neoplasms of the kidney and ureter. An epidemiologic, pathologic, and clinical review. Am J Clin Pathol 117(Suppl):S36-S48
4. Jakob J, Bellach J, Grutzmann R, Alldinger I, Pilarsky C, Dietel M, Kristiansen G (2004) Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades. Pancreatology 4:454-460
5. Jimenez RE, Gheiler E, Oskanian P, Tiguert R, Sakr W, Wood DP Jr, Pontes JE, Grignon DJ (2000) Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol 24:980-987
6. Kirkali Z, Tuzel E (2003) Transitional cell carcinoma of the ureter and the renal pelvis. Crit Rev Oncol Hematol 47:116-155
7. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844-847
8. Kristiansen G, Denkert C, Schlüns K, Dahl E, Pilarsky C, Hauptmann S (2002) CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am J Pathol 161:1251-1221
9. Kristiansen G, Pilarsky C, Pervan J, Sturzebecher B, Stephan C, Jung K, Loening S, Rosenthal A, Dietel M (2004) CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer. J Hered 58:183-192
10. Kristiansen G, Sammar M, Altevogt P (2004) Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol 35:255-262
11. Kristiansen G, Schlüns K, Yongwei Y, Denkert C, Dietel M, Petersen I (2003) CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients. Br J Cancer 88:231-236
12. Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schlüns K, Denkert C, Dahl E, Pilarsky C, Altevogt P, Guski H, Dietel M (2003) CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res 9:4906-4913
13. Langner C, Hutterer G, Chromecki T, Rehak P, Zigeuner R (2006) Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract. Virchows Arch 448:604-611
14. Langner C, Hutterer G, Chromecki T, Winkelmayer I, Rehak P, Zigeuner R (2006) pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract. Mod Pathol 19:272-279
15. Langner C, Rupar G, Leibl S, Hutterer G, Chromecki T, Hoefler G, Rehak P, Zigeuner R (2006) Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression. Virchows Arch 448:325-330
16. Lim SC (2005) CD24 in human carcinomas: tumor biological aspects. Biomed Pharmacother 59(Suppl 2):S351-S354
17. Lim SC, Oh SH (2005) The role of CD24 in various human epithelial neoplasias. Pathol Res Pract 201:479-486
18. Lopez-Beltran A, Sauter G, Gasser T, Hartmann A, Schmitz-Dräger BJ, Helpap B, Ayala AG, Tamboli P, Knowles MA, Sidransky D, Cordon-Cardo C, Jones PA, Cairns P, Simon R, Amin MB, Tyczynski JE (2004) Tumours of the urinary system. Infiltrating urothelial carcinoma. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) World Health Organization classification of tumours. Pathology and genetics. Tumours of the urinary system and male genital organs. IARC, Lyon, pp 93-109
19. Sagiv E, Kazanov D, Arber N (2006) CD24 plays an important role in the carcinogenesis process of the pancreas. Biomed Pharmacother 60:280-284
20. Sagiv E, Memeo L, Karin A, Kazanov D, Jacob-Hirsch J, Mansukhani M, Rechavi G, Hibshoosh H, Arber N (2006) CD24 Is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastroenterology 131:630-639
21. Smith SC, Oxford G, Wu Z (2006) The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer. Cancer Res 66:1917-1922
22. Sobin LH, Wittekind C (eds) (2002) TNM classification of malignant tumors, 6th edn. Wiley, New York
23. Su MC, Hsu C, Kao HL, Jeng YM (2006) CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma. Cancer Lett 235:34-39
24. Surowiak P, Materna V, Gyorffy B, Matkowski R, Wojnar A, Maciejczyk A, Paluchowski P, Dziegiel P (2006) Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers. Br J Cancer 95:339-346
25. Surowiak P, Materna V, Kaplenko I, Spaczynski M, Dietel M, Kristiansen G, Lage H, Zabel M (2006) Unfavorable prognostic value of CD24 expression in sections from primary and relapsed ovarian cancer tissue. Int J Gynecol Cancer 16:515-521
26. Weichert W, Denkert C, Burkhardt M, Gansukh T, Bellach J, Altevogt P, Dietel M, Kristiansen G (2005) Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin Cancer Res 11:6574-6581